Research Focus

Former Employee. Medicine; Clinical Research Supervisor

Recent additions – View all

1. Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma

   Journal Article

   Motzer, R. J.; Amato, R.; Todd, M.; Hwu, W. J. P.; Cohen, R.; Baselga, J.; Muss, H.; Cooper, M.; Yu, R.; Ginsberg, M. S.; more...
   Investigational New Drugs (2003)

   Fulltext@MSK | Save
2. Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma

   Journal Article

   Motzer, R. J.; Rakhit, A.; Ginsberg, M.; Rittweger, K.; Vuky, J.; Yu, R.; Fettner, S.; Hooftman, L.
   Journal of Clinical Oncology (2001)

   Fulltext@MSK | Save
3. Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma

   Journal Article

   Berg, W. J.; Schwartz, L.; Yu, R.; Mazumdar, M.; Motzer, R. J.
   Investigational New Drugs (2001)

   Fulltext@MSK | Save